佳礼资讯网

 找回密码
 注册

ADVERTISEMENT

楼主: wkgareth85

【MTOUCHE 0092 交流专区】万通科技

  [复制链接]
发表于 15-3-2021 05:08 AM | 显示全部楼层
MTOUCHE TECHNOLOGY BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
ESOS
Details of corporate proposal
Exercise of ESOS
No. of shares issued under this corporate proposal
25,082,803
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.0550
Par Value($$) (if applicable)

Latest issued share capital after the above corporate proposal in the following
Units
1,164,983,559
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 143,395,810.975
Listing Date
23 Oct 2020

回复

使用道具 举报


ADVERTISEMENT

发表于 20-5-2021 07:41 AM | 显示全部楼层
本帖最后由 icy97 于 16-9-2021 10:21 AM 编辑
icy97 发表于 25-5-2020 08:42 AM
NGS warrants that the Products sold hereunder shall be of merchantable quality and in accordance with any specifications which may be provided by NGS’s manufacturers and suppliers in the written or ...


Type
Announcement
Subject
OTHERS
Description
MTOUCHE TECHNOLOGY BERHAD ("MTOUCHE" OR "THE COMPANY")PRESS RELEASE - SUPPLY AGREEMENT BETWEEN MTOUCHE INTERNATIONAL SDN. BHD. AND NETWORK GLOBAL SOLUTIONS PTY LTD
For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcements dated 14 April 2020.

Further to the Company’s announcement made on 14 April 2020 on the subject matter, the Board of Directors of mTouche is pleased to announce that the following Novel Coronavirus (SAR-CoV-2) RT-PCR Detection and Diagnostic Kit have been duly assessed and received final decision and approval by Medical Device Authority (MDA), under the purview of Ministry of Health Malaysia (MoH), and is now “Recommended for Use”:-

Manufacturers
Products Name
IVD Test Assay Evaluation By
LabGenomics Co., Ltd.
(South Korea)
LabGun™ COVID-19 RT-PCR Kit
Institute for Medical Research, Malaysia (IMR)
Shanghai Fosun Long March Medical Science Co., Ltd (China)
Fosun COVID-19 RT-PCR Detection Kit
Institute for Medical Research, Malaysia (IMR)
Wuhan EasyDiagnosis Biomedicine Co., Ltd. (China)
COVID-19 (SARS-CoV-2) Nucleic Acid Test Kit
Makmal Kesihatan Awam Kebangsaan, Malaysia (MKAK)

Please refer to the attached press release regarding the subject matter.

This announcement is dated 13 November 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3104800



Type
Announcement
Subject
OTHERS
Description
MTOUCHE TECHNOLOGY BERHAD ("MTOUCHE" OR "THE COMPANY")DIGITAL DISTRIBUTION AGREEMENT BETWEEN MTOUCHE INTERNATIONAL SDN. BHD. AND MLABS RESEARCH SDN. BHD.
For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcements dated 14 April 2020 and 13 November 2020.

Further to the Company’s announcement made on 14 April 2020 and 13 November 2020, the Board of Directors of mTouche Technology Berhad (“MTOUCHE” or the “Company”) wishes to inform that mTouche International Sdn. Bhd. (“MISB”), a wholly owned subsidiary of the Company, had on 19 November 2020 entered into a Digital Distribution Agreement (the “Agreement”) with Mlabs Research Sdn. Bhd. (“Mlabs Research”), to promote, market, and distribute Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel Coronavirus (SAR-CoV-2) lgM/lgG Rapid Test Kit, and other equivalent products in Malaysia through Mlabs digital distribution channel.

Mlabs Research is a wholly owned subsidiary of Mlabs Systems Berhad which the group is engaged in the investment holding, research and development in web conferencing and related products, provision of mobile application solution, online trading of white goods, film productions, and advisory services on digital assets and fintech investment.

The Agreement is to a period of one (1) year, commencing on and from 19 November 2020, unless otherwise mutually extended or terminated. Either party may terminate the Agreement upon delivery of written notice at least thirty (30) days prior to such termination.

The Agreement will not have any effects on the share capital and shareholding structure of the Company. However, it is expected to have positive contribution to the earnings and net assets of MTOUCHE Group.

Similar to all business entities, the risk factors affecting the execution of the Agreement, including but not limited to business risks such as prudent financial management, changes in political, economic and regulatory conditions. However, the Board will continue to exercise due care in considering the risks associated with the Agreement and will take appropriate measures in planning the successful execution of the Agreement.

The Agreement is not subject to the approval of the shareholders.

None of the Directors and/or other major shareholders of the Company and/or any persons connected to them have any interest, direct or indirect, in relation to the Agreement.

The Board, after due consideration, is of the opinion that the Agreement is in the best interest of the Group.

This announcement is dated 19 November 2020.







Type
Announcement
Subject
OTHERS
Description
MTOUCHE TECHNOLOGY BERHAD ("MTOUCHE" OR "THE COMPANY")PRESS RELEASE - DIGITAL DISTRIBUTION AGREEMENT BETWEEN MTOUCHE INTERNATIONAL SDN. BHD. AND MLABS RESEARCH SDN. BHD.
For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcements dated 14 April 2020 and 13 November 2020.

Further to the Company’s announcement made on 14 April 2020 and 13 November 2020, the Board of Directors of mTouche Technology Berhad (“MTOUCHE” or the “Company”) wishes to announce that mTouche International Sdn. Bhd. (“MISB”), a wholly owned subsidiary of the Company, had on 19 November 2020 entered into a Digital Distribution Agreement (the “Agreement”) with Mlabs Research Sdn. Bhd. (“Mlabs Research”), to promote, market, and distribute Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel Coronavirus (SAR-CoV-2) lgM/lgG Rapid Test Kit, and other equivalent products in Malaysia through Mlabs digital distribution channel.

Please refer to the attached press release regarding the subject matter.

This announcement is dated 19 November 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3106548
Attachments



SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2020
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2020
30 Sep 2019
30 Sep 2020
30 Sep 2019
$$'000
$$'000
$$'000
$$'000
1Revenue
1,206
4,613
1,206
4,613
2Profit/(loss) before tax
-1,017
616
-1,017
616
3Profit/(loss) for the period
-1,017
1,437
-1,017
1,437
4Profit/(loss) attributable to ordinary equity holders of the parent
-804
1,596
-804
1,596
5Basic earnings/(loss) per share (Subunit)
-0.08
0.31
-0.11
0.31
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.0751
0.0863




Type
Announcement
Subject
OTHERS
Description
MTOUCHE TECHNOLOGY BERHAD ("MTOUCHE" OR "THE COMPANY")-        MEDICAL DEVICE AUTHORITY ("MDA"), MALAYSIA QUERY AND CLARIFICATION
For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcements dated 14 April 2020 and 13 November 2020.

Further to the Company’s announcements made on 14 April 2020 and 13 November 2020 pertaining to the Novel Coronovirus (SAR-Cov-2) RT-PCR Detection and Diagnostic Kit (COVID-19 Test Kits) have received the MDA’s “Recommended for Use”, with recent query and clarification received from the MDA on 23 November 2020, the Board of the Directors of the Company wishes to clarify and correct the following misstatement.

Under the MDA’s Special Access, no promotional and advertising activities is allowed without prior approval from the MDA. Chapter 9.12(1) of the ACE Market Listing Requirements (“ACE LR”) provides that a listed corporation must refrain from promotional disclosure activity in any form whatsoever or howsoever which may mislead investors or cause unwarranted price movement and activity in a listed corporation’s securities.

The Company wishes to clarify and confirm that the announcement made by the Company on 13 November 2020 is a continuing disclosure pursuant to Chapter 9.02(2)(a) of the ACE LR and the Company does not have any intention or motivation on any promotional related activities.

Besides, please be informed that the Company does not possess the MDA’s Establishment License and Good Distribution Practice for Medical Devices (GDPMD) currently. The Company is collaborating with Premier Diagnostics Sdn. Bhd. who holds the MDA’s Establishment License to apply for the Special Access from the MDA.

With further clarification received from the MDA, the Company is not allowed to “promote, market, distribute” as well as import any of the “Recommended for Use” COVID-19 Test Kits as the Company is not the registered holder for MDA’s Establishment License. Hence, the Company will continue to collaborate with its partner, Premier Diagnostics Sdn. Bhd. for the importation, warehousing and logistic support and the Company may collaborate with other MDA’s Establishment License Distributors for the distribution of the COVID-19 Test Kits.

This announcement is dated 1 December 2020.



Type
Announcement
Subject
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
PROPOSED PRIVATE PLACEMENT
On behalf of the Board of Directors of the Company, Mercury Securities Sdn Bhd wishes to announce that the Company proposes to undertake a private placement of up to 116,498,000 new ordinary shares in the Company, representing approximately 10% of the existing total number of issued shares of the Company (excluding treasury shares) to independent third party investor(s) to be identified later and at an issue price to be determined later (“Proposed Private Placement”).

Please refer to the attachment for further details on the Proposed Private Placement.

This announcement is dated 18 December 2020.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3115377



Type
Announcement
Subject
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
MTOUCHE TECHNOLOGY BERHAD ("MTOUCHE" OR THE "COMPANY")PROPOSED PRIVATE PLACEMENT
(For consistency, the abbreviations used throughout this announcement shall have the same meanings as defined in the announcement dated 18 December 2020 in relation to the Proposed Private Placement, where applicable, unless stated otherwise or defined herein.)

Reference is made to the announcement dated 18 December 2020 in relation to the Proposed Private Placement (“First Announcement”).

On behalf of the Board, Mercury Securities wishes to furnish additional information in furtherance to the First Announcement.

Please refer to the attachment for further details on the additional information.

This announcement is dated 11 January 2021.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3119983



MTOUCHE TECHNOLOGY BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?
No
Types of corporate proposal
Private Placement
Details of corporate proposal
Private Placement of up to 10% of the total number of issued shares of the Company
No. of shares issued under this corporate proposal
116,498,000
Issue price per share ($$)
Malaysian Ringgit (MYR)   0.0618
Par Value($$) (if applicable)

Latest issued share capital after the above corporate proposal in the following
Units
1,281,482,358
Issued Share Capital ($$)
Malaysian Ringgit (MYR) 150,595,547.175
Listing Date
15 Jan 2021


回复

使用道具 举报

发表于 10-10-2021 09:28 AM | 显示全部楼层
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)
MTOUCHE TECHNOLOGY BERHAD
Particulars of Substantial Securities Holder
Name
DGB NETWORKS SDN. BHD.
Address
Third Floor, No. 77, 79 & 81
Jalan SS21/60, Damansara Utama
Petaling Jaya
47400 Selangor
Malaysia.
Company No.
201801012992 (1275008-T)
Nationality/Country of incorporation
Malaysia
Descriptions (Class)
Ordinary Shares
Name of registered holder
M&A Nominee (Tempatan) Sdn. Bhd. Sanston Financial Group Limited for DGB Networks Sdn. Bhd.
Address of registered holder
45-1 & 47-1, Boulevard Mid Valley CityLingkaran Syed Putra59200 Kuala Lumpur
Date interest acquired & no of securities acquired
Date interest acquired
06 Oct 2021
No of securities
48,751,000
Circumstances by reason of which Securities Holder has interest
Acquisition of shares via open market
Nature of interest
Direct Interest
Total no of securities after change
Direct (units)
48,751,000
Direct (%)
5.261
Indirect/deemed interest (units)
0
Indirect/deemed interest (%)
0
Date of notice
08 Oct 2021
Date notice received by Listed Issuer
08 Oct 2021

回复

使用道具 举报

发表于 23-10-2021 11:47 AM | 显示全部楼层
MTOUCHE TECHNOLOGY BERHAD

Particulars of substantial Securities Holder
Name
DGB NETWORKS SDN. BHD.
Address
THIRD FLOOR, NO. 77, 79 & 81
JALAN SS21/60
DAMANSARA UTAMA
PETALING JAYA
47400 Selangor
Malaysia.
Company No.
201801012992 (1275008-T)
Nationality/Country of incorporation
Malaysia
Descriptions (Class)
Ordinary Shares
Details of changes
No
Date of change
No of securities
Type of TransactionNature of Interest
121 Oct 2021
28,000,000
AcquiredDirect Interest
Name of registered holder
DGB Networks Sdn. Bhd.
Address of registered holder
Third Floor, No. 77, 79 & 81 Jalan SS21/60, Damansara Utama 47400 Petaling Jaya Selangor
Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred
Acquisition of shares via open market
Nature of interest
Direct Interest
Direct (units)
79,751,000
Direct (%)
8.606
Indirect/deemed interest (units)
0
Indirect/deemed interest (%)
0
Total no of securities after change
79,751,000
Date of notice
22 Oct 2021
Date notice received by Listed Issuer
22 Oct 2021

回复

使用道具 举报

发表于 5-1-2022 09:41 AM | 显示全部楼层
MTOUCHE TECHNOLOGY BERHAD

Date of change
22 Nov 2021
Name
YM RAJA HIZAD BIN RAJA KAMARULZAMAN
Age
67
Gender
Male
Nationality
Malaysia
Designation
Non Executive Chairman
Directorate
Independent and Non Executive
Type of change
Demised

回复

使用道具 举报

发表于 7-2-2022 10:45 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2021
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
Three Months
Three Months
Fifteen Months
Fifteen Months
01 Jul 2021
To
01 Jul 2020
To
01 Jul 2020
To
01 Jul 2019
To
30 Sep 2021
30 Sep 2020
30 Sep 2021
30 Sep 2021
$$'000
$$'000
$$'000
$$'000
1Revenue
14,619
1,206
18,727
0
2Profit/(loss) before tax
-10,547
-1,017
-22,439
0
3Profit/(loss) for the period
-10,144
-1,017
-22,036
0
4Profit/(loss) attributable to ordinary equity holders of the parent
-10,126
-804
-22,060
0
5Basic earnings/(loss) per share (Subunit)
-1.09
-0.08
-2.17
0.00
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.1708
0.0863

回复

使用道具 举报

Follow Us
发表于 16-9-2024 04:59 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2024
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Jun 2024
30 Jun 2023
30 Jun 2024
30 Jun 2023
$$'000
$$'000
$$'000
$$'000
1Revenue
1,341
1,227
7,959
5,208
2Profit/(loss) before tax
-3,535
-4,131
-5,887
-12,751
3Profit/(loss) for the period
-3,535
-4,131
-5,887
-12,751
4Profit/(loss) attributable to ordinary equity holders of the parent
-3,520
-4,108
-5,824
-12,695
5Basic earnings/(loss) per share (Subunit)
-0.38
-0.44
-0.63
-1.37
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.0793
0.0857

回复

使用道具 举报

发表于 22-9-2024 08:03 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
MTOUCHE TECHNOLOGY BERHAD ("MTOUCHE" OR THE "COMPANY")PROPOSED REDUCTION OF THE ISSUED SHARE CAPITAL OF MTOUCHE OF RM203.00 MILLIONPURSUANT TO SECTION 117 OF THE COMPANIES ACT 2016 ("PROPOSED CAPITAL REDUCTION")
On behalf of the Board of Directors of mTouche, Sierac Corporate Advisers Sdn Bhd wishes to announce that the Company proposes to undertake the Proposed Capital Reduction.

Further details of the Proposed Capital Reduction are set out in the attachment below.

This announcement is dated 13 September 2024.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3483748

回复

使用道具 举报


ADVERTISEMENT

您需要登录后才可以回帖 登录 | 注册

本版积分规则

 

ADVERTISEMENT



ADVERTISEMENT



ADVERTISEMENT

ADVERTISEMENT


版权所有 © 1996-2023 Cari Internet Sdn Bhd (483575-W)|IPSERVERONE 提供云主机|广告刊登|关于我们|私隐权|免控|投诉|联络|脸书|佳礼资讯网

GMT+8, 22-11-2024 04:52 PM , Processed in 0.118622 second(s), 22 queries , Gzip On.

Powered by Discuz! X3.4

Copyright © 2001-2021, Tencent Cloud.

快速回复 返回顶部 返回列表